- testing |
| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 May 2025 | 29 Apr 2025 |
| Audited Results Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 ,inter alia, to consider and approve Audited Financial Results for the Quarter and year ended March 31, 2025 Financial Results for the quarter and year ended March 31, 2025 and appointment of Cost Auditor Outcome of the Board meeting and Financial Results for the quarter and year ended March 31, 2025 (As per BSE Announcement Dated on 06/05/2025) | ||
| Board Meeting | 29 Jan 2025 | 22 Jan 2025 |
| AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 inter alia to consider and approve Financial results for the quarter and nine months ended December 31 2024 and Interim Dividend if any. Financial Resuls and Interim dividend (As Per Bse Announcement Dated on 29.01.2025) | ||
| Board Meeting | 24 Oct 2024 | 17 Oct 2024 |
| AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2024 inter alia to consider and approve Audited financial results for the quarter and half year ended September 30 2024 Financial Results for the quarter and half year ended September 30, 2024 (As per BSE Announcement Dated on 24/10/2024) | ||
| Board Meeting | 26 Aug 2024 | 21 Aug 2024 |
| AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/08/2024 inter alia to consider and approve the proposal of Buyback of equity shares of the Company Outcome of the Board meeting dated August 26, 2024 (As per BSE Announcement Dated on 21/08/2024) | ||
| Board Meeting | 26 Jul 2024 | 19 Jul 2024 |
| AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve This is to inform you that next Board Meeting of the Board of Directors of the Company is scheduled to be held on Friday July 26 2024 to consider approve and take on record Audited Financial Results for the Quarter ended June 30 2024. Outcome of the Board meeting (As per BSE Announcement Dated on 26/07/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.